tiprankstipranks
The Fly

Mirum Pharmaceuticals price target lowered to $60 from $63 at H.C. Wainwright

Mirum Pharmaceuticals price target lowered to $60 from $63 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Mirum Pharmaceuticals to $60 from $63 and keeps a Buy rating on the shares post the Q3 report. The analyst continues to see significant upside for the shares given the anticipated growth of the Livmarli franchise, along with potential expansions into multiple liver diseases on the horizon.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on MIRM:

Questions or Comments about the article? Write to editor@tipranks.com